Immune resilience in response to cancer therapy.
作者信息
Gicobi Joanina K, Barham Whitney, Dong Haidong
机构信息
Mayo Clinic College of Medicine and Science, Mayo Clinic, Rochester, MN, USA.
出版信息
Cancer Immunol Immunother. 2020 Nov;69(11):2165-2167. doi: 10.1007/s00262-020-02731-4.
Abstract
摘要
相似文献
1
Immune resilience in response to cancer therapy.癌症治疗中的免疫恢复力。
Cancer Immunol Immunother. 2020 Nov;69(11):2165-2167. doi: 10.1007/s00262-020-02731-4.
2
Combination Immunotherapy with CAR T Cells and Checkpoint Blockade for the Treatment of Solid Tumors.嵌合抗原受体 T 细胞与免疫检查点抑制剂联合治疗实体瘤。
Cancer Cell. 2019 Nov 11;36(5):471-482. doi: 10.1016/j.ccell.2019.09.006.
3
Development of adaptive immune effector therapies in solid tumors.实体瘤中适应性免疫效应疗法的发展。
Ann Oncol. 2019 Nov 1;30(11):1740-1750. doi: 10.1093/annonc/mdz285.
4
Drug resistance and new therapies in colorectal cancer.结直肠癌的耐药性和新疗法。
World J Gastroenterol. 2018 Sep 14;24(34):3834-3848. doi: 10.3748/wjg.v24.i34.3834.
5
Firing Up Cold Tumors.激活冷肿瘤
Trends Cancer. 2019 Sep;5(9):528-530. doi: 10.1016/j.trecan.2019.06.005. Epub 2019 Jul 13.
6
Vascular Targeting to Increase the Efficiency of Immune Checkpoint Blockade in Cancer.血管靶向以提高癌症免疫检查点阻断的效率。
Front Immunol. 2018 Dec 21;9:3081. doi: 10.3389/fimmu.2018.03081. eCollection 2018.
7
Killing the "BAD": Challenges for immunotherapy in pancreatic cancer.杀伤“BAD”：胰腺癌免疫治疗的挑战。
Biochim Biophys Acta Rev Cancer. 2020 Aug;1874(1):188384. doi: 10.1016/j.bbcan.2020.188384. Epub 2020 Jun 9.
8
Prognostic significance of tumor immune microenvironment and immunotherapy: Novel insights and future perspectives in gastric cancer.肿瘤免疫微环境与免疫治疗的预后意义：胃癌的新见解和未来展望。
World J Gastroenterol. 2018 Aug 28;24(32):3583-3616. doi: 10.3748/wjg.v24.i32.3583.
9
Prostate cancer immunotherapy: where are we and where are we going?前列腺癌免疫疗法：我们目前的状况与未来的发展方向？
Curr Opin Urol. 2018 Jan;28(1):15-24. doi: 10.1097/MOU.0000000000000462.
10
Modulation of the tumor microenvironment by intratumoral administration of IMO-2125, a novel TLR9 agonist, for cancer immunotherapy.肿瘤内注射新型 TLR9 激动剂 IMO-2125 调节肿瘤微环境用于癌症免疫治疗。
Int J Oncol. 2018 Sep;53(3):1193-1203. doi: 10.3892/ijo.2018.4456. Epub 2018 Jun 27.
引用本文的文献
1
T cell exhaustion in pediatric B-ALL: current knowledge and future perspectives.儿童B淋巴细胞白血病中的T细胞耗竭：当前认知与未来展望
Front Immunol. 2025 May 28;16:1531145. doi: 10.3389/fimmu.2025.1531145. eCollection 2025.
2
Salvage therapy expands highly cytotoxic and metabolically fit resilient CD8 T cells via ME1 up-regulation.挽救性治疗通过上调 ME1 来扩增高细胞毒性和代谢适应性强的 CD8 T 细胞。
Sci Adv. 2023 Nov 17;9(46):eadi2414. doi: 10.1126/sciadv.adi2414. Epub 2023 Nov 15.
3
Recent Advances in Molecular Mechanisms of Cancer Immunotherapy.癌症免疫治疗分子机制的最新进展
Cancers (Basel). 2023 May 11;15(10):2721. doi: 10.3390/cancers15102721.
4
Resilient T-cell responses in patients with advanced cancers.晚期癌症患者的 T 细胞具有较强的免疫反应能力。
Int J Hematol. 2023 May;117(5):634-639. doi: 10.1007/s12185-022-03424-7. Epub 2022 Jul 21.
5
A T cell resilience model associated with response to immunotherapy in multiple tumor types.一种与多种肿瘤类型免疫治疗反应相关的 T 细胞恢复力模型。
Nat Med. 2022 Jul;28(7):1421-1431. doi: 10.1038/s41591-022-01799-y. Epub 2022 May 2.
6
Immunosuppressive Signaling Pathways as Targeted Cancer Therapies.作为靶向癌症治疗的免疫抑制信号通路
Biomedicines. 2022 Mar 16;10(3):682. doi: 10.3390/biomedicines10030682.
本文引用的文献
1
Peripheral T cell expansion predicts tumour infiltration and clinical response.外周 T 细胞扩增可预测肿瘤浸润和临床反应。
Nature. 2020 Mar;579(7798):274-278. doi: 10.1038/s41586-020-2056-8. Epub 2020 Feb 26.
2
Peripheral CD8 T cell characteristics associated with durable responses to immune checkpoint blockade in patients with metastatic melanoma.外周血 CD8 T 细胞特征与转移性黑色素瘤患者对免疫检查点阻断的持久应答相关。
Nat Med. 2020 Feb;26(2):193-199. doi: 10.1038/s41591-019-0734-6. Epub 2020 Feb 10.
3
CD4 T Cell Help Is Required for the Formation of a Cytolytic CD8 T Cell Subset that Protects against Chronic Infection and Cancer.CD4 T 细胞辅助对于形成保护性细胞毒性 CD8 T 细胞亚群以抵抗慢性感染和癌症是必需的。
Immunity. 2019 Dec 17;51(6):1028-1042.e4. doi: 10.1016/j.immuni.2019.10.009. Epub 2019 Dec 3.
4
Proliferating Transitory T Cells with an Effector-like Transcriptional Signature Emerge from PD-1 Stem-like CD8 T Cells during Chronic Infection.在慢性感染期间，具有效应样转录特征的增殖暂态 T 细胞从 PD-1 干性 CD8 T 细胞中出现。
Immunity. 2019 Dec 17;51(6):1043-1058.e4. doi: 10.1016/j.immuni.2019.11.002. Epub 2019 Dec 3.
5
Clonal replacement of tumor-specific T cells following PD-1 blockade.PD-1 阻断后肿瘤特异性 T 细胞的克隆性替换。
Nat Med. 2019 Aug;25(8):1251-1259. doi: 10.1038/s41591-019-0522-3. Epub 2019 Jul 29.
6
CX3CR1 identifies PD-1 therapy-responsive CD8+ T cells that withstand chemotherapy during cancer chemoimmunotherapy.CX3CR1 鉴定了在癌症化疗免疫治疗期间能够耐受化疗的 PD-1 治疗反应性 CD8+ T 细胞。
JCI Insight. 2018 Apr 19;3(8). doi: 10.1172/jci.insight.97828.
7
Molecular and cellular insights into T cell exhaustion.对T细胞耗竭的分子和细胞层面的见解。
Nat Rev Immunol. 2015 Aug;15(8):486-99. doi: 10.1038/nri3862.
8
Heterogeneous differentiation patterns of individual CD8+ T cells.个体 CD8+ T 细胞的异质性分化模式。
Science. 2013 May 3;340(6132):635-9. doi: 10.1126/science.1235487. Epub 2013 Mar 14.
9
Disparate individual fates compose robust CD8+ T cell immunity.不同个体的命运构成了强大的 CD8+ T 细胞免疫。
Science. 2013 May 3;340(6132):630-5. doi: 10.1126/science.1235454. Epub 2013 Mar 14.
10
Cancer: a biological approach. III. Viruses associated with neoplastic conditions. IV. Practical applications.癌症：生物学视角。III. 与肿瘤形成相关的病毒。IV. 实际应用。
Br Med J. 1957 Apr 13;1(5023):841-7. doi: 10.1136/bmj.1.5023.841.
Zotero 插件